Literature DB >> 28993958

Functional Evaluation of an IKBKG Variant Suspected to Cause Immunodeficiency Without Ectodermal Dysplasia.

Glynis Frans1, Jutte van der Werff Ten Bosch2, Leen Moens1, Rik Gijsbers3,4, Majid Changi-Ashtiani5, Hassan Rokni-Zadeh6, Mohammad Shahrooei7,8, Greet Wuyts1, Isabelle Meyts9,10, Xavier Bossuyt11,12.   

Abstract

Hypomorphic IKBKG mutations in males are typically associated with anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID). Some mutations cause immunodeficiency without EDA (NEMO-ID). The immunological profile associated with these NEMO-ID variants is not fully documented. We present a 2-year-old patient with suspected immunodeficiency in which a hemizygous p.Glu57Lys IKBKG variant was identified. At the age of 1 year, he had an episode of otitis media that evolved into a bilateral mastoiditis (Pseudomonas spp). Hypogammaglobulinemia, specific (polysaccharide) antibody deficiency, and low switched memory B cell subsets were noticed. The mother was heterozygous for the variant but had no signs of incontinentia pigmenti. Patient peripheral blood mononuclear cells produced low amounts of IL-6 after stimulation with IL-1β, Pam3CSK4, and FSL-1. In patient fibroblasts, IκB-α was degraded normally upon stimulation with IL-1β or TNF-α. Transduction of wild-type and variant NEMO in NEMO-/- deficient SV40 fibroblasts revealed a slight but significant reduction of IL-6 production upon stimulation with IL-1β and TNF-α. In conclusion, we demonstrated that p.Glu57Lys leads to specific immunological defects in vitro. No other pathogenic PID variants were identified through whole exome sequencing. As rare polymorphisms have been described in IKBKG and polygenic inheritance remains an option in the presented case, this study emphasizes the need for thorough functional and genetic evaluation when encountering and interpreting suspected disease-causing NEMO-ID variants.

Entities:  

Keywords:  Immunodeficiency; NEMO; NF-κB essential modulator; NF-κB pathway; toll-like receptors

Mesh:

Substances:

Year:  2017        PMID: 28993958     DOI: 10.1007/s10875-017-0448-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  37 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Human IκBα Gain of Function: a Severe and Syndromic Immunodeficiency.

Authors:  Bertrand Boisson; Anne Puel; Capucine Picard; Jean-Laurent Casanova
Journal:  J Clin Immunol       Date:  2017-06-09       Impact factor: 8.317

3.  Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia.

Authors:  Yang-Shia Dai; Marilyn G Liang; Stephen E Gellis; Francisco A Bonilla; Lynda C Schneider; Raif S Geha; Jordan S Orange
Journal:  J Am Acad Dermatol       Date:  2004-11       Impact factor: 11.527

4.  Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity.

Authors:  Ralf B Marienfeld; Lysann Palkowitsch; Sankar Ghosh
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

5.  Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia.

Authors:  Tim Niehues; Janine Reichenbach; Jennifer Neubert; Sonja Gudowius; Anne Puel; Gerd Horneff; Elke Lainka; Uta Dirksen; Horst Schroten; Rainer Döffinger; Jean Laurent Casanova; Volker Wahn
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

Review 6.  Novel Mutation of ZAP-70-related Combined Immunodeficiency: First Case from the National Iranian Registry and Review of the Literature.

Authors:  Afshin Shirkani; Mohammad Shahrooei; Gholamreza Azizi; Hassan Rokni-Zadeh; Hassan Abolhassani; Shokrollah Farrokhi; Glynis Frans; Xavier Bossuyt; Asghar Aghamohammadi
Journal:  Immunol Invest       Date:  2016-10-19       Impact factor: 3.657

7.  The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation.

Authors:  Jordan S Orange; Ashish Jain; Zuhair K Ballas; Lynda C Schneider; Raif S Geha; Francisco A Bonilla
Journal:  J Allergy Clin Immunol       Date:  2004-04       Impact factor: 10.793

8.  Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity.

Authors:  Eric P Hanson; Linda Monaco-Shawver; Laura A Solt; Lisa A Madge; Pinaki P Banerjee; Michael J May; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2008-10-11       Impact factor: 10.793

9.  Optimal assessment of the ability of children with recurrent respiratory tract infections to produce anti-polysaccharide antibodies.

Authors:  D Tuerlinckx; F Vermeulen; V Pékus; G de Bilderling; Y Glupczynski; S Collet; J Jamart; E Bodart; F Mascart
Journal:  Clin Exp Immunol       Date:  2007-05-18       Impact factor: 4.330

10.  X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.

Authors:  Orchidée Filipe-Santos; Jacinta Bustamante; Margje H Haverkamp; Emilie Vinolo; Cheng-Lung Ku; Anne Puel; David M Frucht; Karin Christel; Horst von Bernuth; Emmanuelle Jouanguy; Jacqueline Feinberg; Anne Durandy; Brigitte Senechal; Ariane Chapgier; Guillaume Vogt; Ludovic de Beaucoudrey; Claire Fieschi; Capucine Picard; Meriem Garfa; Jalel Chemli; Mohamed Bejaoui; Maria N Tsolia; Necil Kutukculer; Alessandro Plebani; Luigi Notarangelo; Christine Bodemer; Frédéric Geissmann; Alain Israël; Michel Véron; Maike Knackstedt; Ridha Barbouche; Laurent Abel; Klaus Magdorf; Dominique Gendrel; Fabrice Agou; Steven M Holland; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  3 in total

1.  Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency.

Authors:  Bertrand Boisson; Yoshitaka Honda; Masahiko Ajiro; Jacinta Bustamante; Matthieu Bendavid; Andrew R Gennery; Yuri Kawasaki; Jose Ichishima; Mitsujiro Osawa; Hiroshi Nihira; Takeshi Shiba; Takayuki Tanaka; Maya Chrabieh; Benedetta Bigio; Hong Hur; Yuval Itan; Yupu Liang; Satoshi Okada; Kazushi Izawa; Ryuta Nishikomori; Osamu Ohara; Toshio Heike; Laurent Abel; Anne Puel; Megumu K Saito; Jean-Laurent Casanova; Masatoshi Hagiwara; Takahiro Yasumi
Journal:  J Clin Invest       Date:  2018-12-18       Impact factor: 14.808

2.  Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected Findings.

Authors:  Francesc Rudilla; Clara Franco-Jarava; Mónica Martínez-Gallo; Marina Garcia-Prat; Andrea Martín-Nalda; Jacques Rivière; Aina Aguiló-Cucurull; Laura Mongay; Francisco Vidal; Xavier Solanich; Iñaki Irastorza; Juan Luis Santos-Pérez; Jesús Tercedor Sánchez; Ivon Cuscó; Clara Serra; Noelia Baz-Redón; Mónica Fernández-Cancio; Carmen Carreras; José Manuel Vagace; Vicenç Garcia-Patos; Ricardo Pujol-Borrell; Pere Soler-Palacín; Roger Colobran
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

3.  Whole Exome Sequencing Revealed a Novel GJB1 Pathogenic Variant and a Rare BSCL2 Mutation in Two Iranian Large Pedigrees with Multiple Affected Cases of Charcot-Marie-Tooth.

Authors:  Neda Mohsenpour; Hassan Roknizadeh; Mehdi Maghbooli; Majid Changi-Ashtiani; Mohammad Shahrooei; Mansoor Salehi; Mahdiyeh Behnam; Tina Shahani; Alireza Biglari
Journal:  Int J Mol Cell Med       Date:  2019
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.